# Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like Symptoms

> **NCT03629184** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 173 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Baloxavir Marboxil
- **DRUG:** Oseltamivir

## Key facts

- **NCT ID:** NCT03629184
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-20
- **Primary completion:** 2019-04-03
- **Final completion:** 2019-04-03
- **Target enrollment:** 173 (ACTUAL)
- **Last updated:** 2020-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03629184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03629184, "Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like Symptoms". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03629184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*